ValueSet Comparison between http://smart.who.int/immunizations/ValueSet/IMMZD18SMeaslesOngoingTransmissionVS vs http://smart.who.int/immunizations/ValueSet/IMMZD18SMeaslesOngoingTransmissionVS

Messages

ErrorValueSet.versionValues for version differ: '1.0.0' vs '0.2.0'
InformationValueSet.dateValues for date differ: '2026-10-02T09:40:20+00:00' vs '2026-10-06T15:33:49+00:00'
InformationValueSet.jurisdictionAdded the item 'null#null'

Metadata

NameValueComments
.compose.inactive
    .compose.lockedDate
      .copyright
        .date2026-10-02T09:40:20+00:002026-10-06T15:33:49+00:00
        • Values Differ
        .descriptionValueSet IMMZD18SMeaslesOngoingTransmission for IMMZ.D18.S.Measles.Ongoing transmission schedule. Business rule: Determine if the client is due for a measles vaccination according to the national immunization schedule Trigger: IMMZ.D2 Determine required vaccination(s) if any Table: Countries with ongoing transmission in which the risk of measles mortality remains high (countries that provide first dose of measles-containing vaccine (MCV) at 9 months and second dose of MCV at 15 months)
          .experimental
            .immutable
              .jurisdiction
                ..jurisdiction[0]null#null
                • Added the item 'null#null'
                .nameIMMZD18SMeaslesOngoingTransmissionVS
                  .publisherWHO
                    .purpose
                      .statusactive
                        .titleIMMZD18SMeaslesOngoingTransmission ValueSet for Decision Table
                          .urlhttp://smart.who.int/immunizations/ValueSet/IMMZD18SMeaslesOngoingTransmissionVS
                            .version1.0.00.2.0
                            • Values Differ

                            Definition

                            ItemPropertyValueComments
                            .includehttp://smart.who.int/immunizations/CodeSystem/IMMZDAK
                              ..ConceptChild's birth-0Child's birth
                                ..ConceptMCV1 was administered-127MCV1 was administered
                                  ..ConceptMCV2 was administered. The primary series has been completed.-104MCV2 was administered. The primary series has been completed.

                                    Expansion

                                    Unable to generate expansion - see errors